Key facts
- Counterfeit versions of the experimental weight-loss drug retatrutide are being sold illicitly in the UK.
- These fake drugs are available through various channels, including gyms, beauty salons, and social media.
- Experts warn that these products may contain unknown ingredients, contaminants, or incorrect dosages.
- Users have reported severe side effects such as nausea, vomiting, diarrhea, and kidney failure.
- Eli Lilly is actively pursuing legal action against those involved in the production and sale of counterfeit retatrutide.
Excitement surrounding the development of new weight-loss drugs has led to a surge in counterfeit versions of Eli Lilly's experimental drug, retatrutide, flooding the black market. Despite not yet being approved for human use by any regulatory body, illicit copies are being sold through various channels, including gyms, beauty salons, and online platforms.
Experts are warning that these counterfeit products pose significant health risks, as they may contain unknown ingredients, harmful contaminants, or incorrect amounts of the active substance. Some individuals who have taken these fake drugs have experienced severe side effects, including nausea, vomiting, diarrhea, and even kidney failure. One individual, Tom Davies, recounted a harrowing experience after accidentally taking eight times the recommended dose of a fake retatrutide, which left him feeling severely unwell and close to requiring hospital treatment.
Pharmacists and doctors are urging caution, highlighting that users of these illicit drugs are essentially acting as unregulated test subjects. Unlike participants in legitimate clinical trials, individuals sourcing these drugs independently lack medical oversight, rigorous screening, and access to proper medical advice. Eli Lilly itself has issued strong warnings against using any product claiming to be retatrutide outside of their sponsored clinical trials, emphasizing the potential dangers of unknown ingredients and incorrect dosages.
Despite the risks, the allure of rapid weight loss continues to drive demand for these counterfeit drugs. Users are sharing their experiences and results on social media, with some reporting positive outcomes such as reduced cravings and weight loss. However, medical professionals stress that the effectiveness and safety of these fake versions can vary drastically, and what works for one person may be harmful to another. The drug, if eventually approved, would be the first to act on three hormone receptors (GLP-1, GIP, and glucagon) to aid weight loss, earning it the nickname 'triple G'. Eli Lilly is actively working to combat the illegal sales by taking action against peptide companies, influencers, compounding pharmacies, and wellness clinics involved in distributing the counterfeit products.